| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -24.15M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
| Period | Total return |
|---|---|
| All-time high | $49.16 (Aug 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in COAG would be worth today ›No. Hemab Therapeutics Holdings, Inc. has not paid a dividend in the past 12 months.
Hemab Therapeutics Holdings, Inc. stock trades on NASDAQ under the ticker symbol COAG.
Hemab Therapeutics Holdings, Inc. is part of the Healthcare sector.
Hemab Therapeutics Holdings, Inc. has a market cap of 2.30B USD, based on the latest quote.
Hemab Therapeutics Holdings, Inc. is expected to report earnings around Nov 16, 2026. That date is an estimate and has not been confirmed by the company.
